Several other analysts have also issued reports on STKL. Zacks Investment Research lowered SunOpta from a hold rating to a sell rating in a research note on Wednesday, October 12th. AltaCorp Capital restated an outperform rating on shares of SunOpta in a research note on Tuesday, June 21st. Wunderlich began coverage on SunOpta in a research note on Tuesday, October 11th. They issued a buy rating and a $10.00 price objective on the stock. Citigroup Inc. upped their price objective on SunOpta from $5.50 to $8.00 and gave the company a buy rating in a research note on Friday, September 9th. Finally, TheStreet upgraded SunOpta from a sell rating to a hold rating in a research note on Wednesday, August 3rd. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the company’s stock. The stock currently has an average rating of Buy and an average target price of $8.88.
Shares of SunOpta (NASDAQ:STKL) opened at 6.65 on Wednesday. The company has a 50-day moving average price of $6.79 and a 200 day moving average price of $5.43. The firm’s market cap is $569.33 million. SunOpta has a 52 week low of $3.16 and a 52 week high of $7.40.
SunOpta (NASDAQ:STKL) last released its quarterly earnings data on Wednesday, August 10th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by $0.02. The business earned $348.10 million during the quarter, compared to the consensus estimate of $361.55 million. SunOpta had a negative net margin of 3.33% and a positive return on equity of 3.45%. SunOpta’s quarterly revenue was up 25.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.08 EPS. Analysts expect that SunOpta will post $0.21 EPS for the current fiscal year.
Institutional investors have recently made changes to their positions in the company. Gamco Investors INC. ET AL raised its position in shares of SunOpta by 1.0% in the second quarter. Gamco Investors INC. ET AL now owns 29,300 shares of the company’s stock worth $123,000 after buying an additional 300 shares during the period. Dimensional Fund Advisors LP raised its position in shares of SunOpta by 1.0% in the second quarter. Dimensional Fund Advisors LP now owns 196,066 shares of the company’s stock worth $822,000 after buying an additional 1,959 shares during the period. Quantum Capital Management raised its position in shares of SunOpta by 71.3% in the first quarter. Quantum Capital Management now owns 29,598 shares of the company’s stock worth $132,000 after buying an additional 12,315 shares during the period. KCG Holdings Inc. raised its position in shares of SunOpta by 194.2% in the second quarter. KCG Holdings Inc. now owns 32,962 shares of the company’s stock worth $138,000 after buying an additional 21,759 shares during the period. Finally, Aperio Group LLC raised its position in shares of SunOpta by 33.5% in the first quarter. Aperio Group LLC now owns 135,232 shares of the company’s stock worth $603,000 after buying an additional 33,927 shares during the period. Institutional investors own 76.82% of the company’s stock.
SunOpta Company Profile
SunOpta Inc operates businesses focused on a healthy products portfolio. The Company operates through two segments: Global Ingredients and Consumer Products. Its Global Ingredients segment aggregates its North American and international raw material sourcing and supply operating segments focused on the procurement, processing and sale of specialty and organic grains and seeds, fruits, grain- and cocoa-based ingredients, and other commodities.
Receive News & Ratings for SunOpta Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SunOpta Inc. and related companies with MarketBeat.com's FREE daily email newsletter.